DFE Pharma

Goch, Germany Founded: 2011 • Age: 15 yrs Acquired By CVC
Developer and manufacturer of excipients for oral solid dosage forms and dry powder inhalations
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About DFE Pharma

DFE Pharma is a company based in Goch (Germany) founded in 2011 was acquired by CVC in September 2019. DFE Pharma operates in a competitive market with competitors including Colorcon, SPI Pharma, Pfanstiehl, Meggle Pharma and JRS Pharma, among others.

  • Headquarter Goch, Germany
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    CVC

    (Sep 25, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of DFE Pharma

Headcount 200-500
Employee Profiles 1
Employee Profiles
People
Martti Hedman
Advisor

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of DFE Pharma

Investors in DFE Pharma

DFE Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CVC.

All
Venture Fund
Investor Description Founded Year Domain Location
Mezzanine financing and equity investments are provided by CVC.
Founded Year Domain Location

Investments & Acquisitions by DFE Pharma

Investments

Financial Statements - DFE Pharma

Dfe Pharma Comparisons

+
Add Comparison
Available on Premium

Competitors of DFE Pharma

DFE Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Colorcon, SPI Pharma, Pfanstiehl, Meggle Pharma and JRS Pharma, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of specialty excipients and corporate-backed venture capital fund focused on healthcare startups
domain founded_year HQ Location
Excipient products and formulations are manufactured for pharmaceutical uses.
domain founded_year HQ Location
APIs, injectable excipients, and bioprocessing solutions are manufactured.
domain founded_year HQ Location
Develops and manufactures pharmaceutical excipients for the industry.
domain founded_year HQ Location
Supplies excipients, coatings, and technical services for health sciences worldwide.

Latest news on Dfe Pharma

Frequently Asked Questions about DFE Pharma

DFE Pharma was founded in 2011.

DFE Pharma is headquartered in Goch, Germany. It is registered at Goch, North Rhine-westphalia, Germany.

Martti Hedman is the current CEO of DFE Pharma.

DFE Pharma is engaged in the development, manufacturing, and marketing of excipients for oral solid dosage forms and dry powder inhalation formulations. They offer their services for pharmaceutical companies all over the globe for the development of products and also in improving the performance of existing drugs. The company specializes in proprietary excipients such as microcrystalline cellulose, starch and lactose, while they also develop excipients for dry powder inhalations and superdisintegrants. The company is jointly owned by Royal FrieslandCampina and Fonterra, multinational dairy companies.

DFE Pharma's top competitors include Colorcon, Crest Cellulose and Scope Ingredients.

DFE Pharma has 1 investor. Key investors include CVC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available